pyrazole has been researched along with Triple Negative Breast Neoplasms in 1 studies
1H-pyrazole : The 1H-tautomer of pyrazole.
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gutierrez, DA | 1 |
| Contreras, L | 1 |
| Villanueva, PJ | 1 |
| Borrego, EA | 1 |
| Morán-Santibañez, K | 1 |
| Hess, JD | 1 |
| DeJesus, R | 1 |
| Larragoity, M | 1 |
| Betancourt, AP | 1 |
| Mohl, JE | 1 |
| Robles-Escajeda, E | 1 |
| Begum, K | 1 |
| Roy, S | 1 |
| Kirken, RA | 1 |
| Varela-Ramirez, A | 1 |
| Aguilera, RJ | 1 |
1 other study available for pyrazole and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Identification of a Potent Cytotoxic Pyrazole with Anti-Breast Cancer Activity That Alters Multiple Pathways.
Topics: Caspases; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Screenin | 2022 |